- Home
- HYFM vs OMGA Comparison
HYFM vs OMGA Comparison
Compare HYFM & OMGA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HYFM
- OMGA
- Stock Information
- Founded
- HYFM 1977
- OMGA 2017
- Country
- HYFM United States
- OMGA United States
- Employees
- HYFM N/A
- OMGA N/A
- Industry
- HYFM Industrial Machinery/Components
- OMGA Biotechnology: Pharmaceutical Preparations
- Sector
- HYFM Industrials
- OMGA Health Care
- Exchange
- HYFM Nasdaq
- OMGA Nasdaq
- Market Cap
- HYFM 28.6M
- OMGA 27.1M
- IPO Year
- HYFM 2020
- OMGA 2021
- Fundamental
- Price
- HYFM $5.79
- OMGA $0.16
- Analyst Decision
- HYFM Hold
- OMGA Strong Buy
- Analyst Count
- HYFM 2
- OMGA 5
- Target Price
- HYFM $0.70
- OMGA $9.20
- AVG Volume (30 Days)
- HYFM 20.0K
- OMGA 26.1M
- Earning Date
- HYFM 03-05-2025
- OMGA 03-27-2025
- Dividend Yield
- HYFM N/A
- OMGA N/A
- EPS Growth
- HYFM N/A
- OMGA N/A
- EPS
- HYFM N/A
- OMGA N/A
- Revenue
- HYFM $200,158,000.00
- OMGA $8,095,000.00
- Revenue This Year
- HYFM N/A
- OMGA $181.38
- Revenue Next Year
- HYFM $3.93
- OMGA N/A
- P/E Ratio
- HYFM N/A
- OMGA N/A
- Revenue Growth
- HYFM N/A
- OMGA 185.04
- 52 Week Low
- HYFM $4.30
- OMGA $0.10
- 52 Week High
- HYFM $12.00
- OMGA $4.46
- Technical
- Relative Strength Index (RSI)
- HYFM 44.33
- OMGA 31.40
- Support Level
- HYFM $5.30
- OMGA $0.15
- Resistance Level
- HYFM $6.61
- OMGA $0.25
- Average True Range (ATR)
- HYFM 0.54
- OMGA 0.08
- MACD
- HYFM -0.02
- OMGA 0.01
- Stochastic Oscillator
- HYFM 44.72
- OMGA 16.02
About HYFM Hydrofarm Holdings Group Inc.
Hydrofarm Holdings Group Inc is a distributor and manufacturer of agriculture equipment and supplies. Some of its products includes lighting solutions, growing media (i.e., premium soils and soil alternatives), nutrients, equipment, and supplies sold under proprietary, exclusive/preferred brands, or non-exclusive/distributed brands. The business is organized into two operating segments, the U.S. and Canada.
About OMGA Omega Therapeutics Inc.
Omega Therapeutics Inc is a development-stage biotechnology company leveraging its proprietary epigenomic programming platform to biologically engineer a new class of programmable epigenetic medicines, known as Omega Epigenomic Controllers. Using epigenomic controllers, Omega is seeking to transform the practice of human medicine through selective and direct control of the human genome to treat and cure disease. It operates in the U.S.